STEMart Launches Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment
STEMart announces the launch of its Bacterial Reverse Mutation Test (Ames) service. New York, United States, September 15, 2025 — STEMart, a US-based provider of comprehensive services for all phases of medical device development, announced… Read More »STEMart Launches Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment




